المؤلفون: Antonio Antón, Elena Aguirre, Mirta García, Maria Martinez-Garcia, Jose Perez-Garcia, Yolanda Fernández, I Garau, Vanesa Ortega, Noemia Afonso, Javier Cortes, Pilar Zamora, César Augusto Rodríguez Sánchez, Esperanza J. Carcache de Blanco, JJ Illarramendi, Antonio Llombart-Cussac, Miguel Sampayo, Lourdes Calvo

المصدر: CLINICAL BREAST CANCER
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Bridged-Ring Compounds, Cancer Research, medicine.medical_specialty, Receptor, ErbB-2, medicine.medical_treatment, Antineoplastic Agents, Breast Neoplasms, Neutropenia, Antimitotic Agents, 03 medical and health sciences, chemistry.chemical_compound, Young Adult, 0302 clinical medicine, Breast cancer, Internal medicine, Medicine, Humans, Eribulin, Neoplasm Metastasis, skin and connective tissue diseases, Adverse effect, Furans, Aged, Aged, 80 and over, Chemotherapy, Taxane, business.industry, First-line chemotherapy, Ketones, Middle Aged, medicine.disease, Metastatic breast cancer, Aggressive taxane-pretreated patients, Regimen, 030104 developmental biology, Treatment Outcome, chemistry, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Female, Taxoids, business, HER2-negative

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05e9555be8996c2b811d335e5175db4d
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8416